HCWBHCW BiologicsHCWB info
$0.41info-0.24%24h
Global rank29524
Market cap$14.86M
Change 7d10.43%
YTD Performance-66.69%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    HCW Biologics (HCWB) Stock Overview

    HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.

    HCWB Stock Information

    Symbol
    HCWB
    Address
    2929 North Commerce ParkwayMiramar, FL 33025United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.hcwbiologics.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    954 842 2024

    HCW Biologics (HCWB) Price Chart

    -
    Value:-

    HCW Biologics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.41299999
    N/A
    Market Cap
    $14.86M
    N/A
    Shares Outstanding
    35.97M
    N/A
    Employees
    44.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org